Today marks the launch of “Refer a Friend,” a new feature from Allē, Allergan Aesthetics’ Loyalty Rewards Program. Allē members can now invite friends and family to join, allowing both parties to save on Allergan Aesthetics products and treatments from brands such as BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, SKINVIVE by JUVÉDERM®, CoolSculpting®, SkinMedica®, and DiamondGlow®.
“When considering new aesthetics treatments, people often seek advice from friends and family. Research shows that 92% of consumers trust these referrals more than other forms of advertising,” said Jasson Gilmore, Senior Vice President, U.S. Aesthetics. “Additionally, 86% of Allē members are highly likely to recommend Allē to others. Whether you are new to Allē or a long-time member, we encourage you to use Refer a Friend and benefit from the rewards.”
How It Works:
- Refer Your Friends: Allē members can refer up to five new users per offer period using a unique referral code.
- New Members Receive Up to $50: When a new user signs up with a referral code, they receive $50 off their first Allergan Aesthetics product or treatment.
- Earn Up to $50 in Savings: The referring member receives a $10 reward after the new user’s first purchase. Members can earn up to $50 for referring five friends, while supplies last. Full details are available in the Allē app.
“Word-of-mouth referrals are crucial for attracting new patients and growing our practice,” said Shawna Chrisman, NP, founder of Destination Aesthetics™, Inc. “The new Refer a Friend feature makes it easier to leverage referrals and build relationships with new patients.”
Serving over seven million members across 27,000 practices, Allē aims to educate consumers about aesthetic treatments. It is the only loyalty program in the aesthetics market that also offers points for over 50 non-Allergan Aesthetics treatments and brands. Allē provides members with information, tools, and incentives to help them on their treatment journey.
For more information or to join Allē, visit www.alle.com. Providers interested in engaging with Allē for Business should contact their local Allergan Aesthetics Business Development Manager.
*Allē Refer a Friend offer values and maximums are subject to changeAllergan Aesthetics, an AbbVie company, develops, manufactures, and markets a portfolio of leading aesthetics brands and products. Our goal is to consistently deliver innovation, education, exceptional service, and a commitment to excellence.
AbbVie is dedicated to discovering and delivering innovative medicines and solutions that address serious health issues and the medical challenges of tomorrow. We focus on immunology, oncology, neuroscience, and eye care, and offer products and services in our Allergan Aesthetics portfolio. For more information, visit www.abbvie.com and follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
BOTOX® Cosmetic Important Safety Information and Approved Uses
BOTOX® Cosmetic is a prescription medicine for temporarily improving the look of moderate to severe forehead lines, crow’s feet lines, and frown lines in adults.
IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects. Get medical help if you experience problems swallowing, speaking, or breathing, or any symptoms of the spread of toxin effects. BOTOX® Cosmetic may cause loss of strength, vision problems, or dizziness. Serious allergic reactions have also been reported.
Do not use BOTOX® Cosmetic if you are allergic to its ingredients or if you have had an allergic reaction to other botulinum toxin products. Discuss your medical history and medications with your doctor to avoid adverse reactions.
For full safety information, refer to the Medication Guide and consult your doctor. To report side effects, call Allergan at 1-800-678-1605.
JUVÉDERM® Injectable Gel Fillers Important Information
Approved uses for JUVÉDERM® products include treating jawline definition, age-related volume loss, moderate to severe facial wrinkles, lip augmentation, and undereye hollows in adults over 21.
IMPORTANT SAFETY INFORMATION
Do not use JUVÉDERM® products if you have severe allergies or a history of allergic reactions to lidocaine or Gram-positive bacterial proteins. Risks include unintentional injection into blood vessels, leading to serious complications like vision abnormalities, stroke, or scarring. Avoid treatment if you have skin sores or infections.
Discuss your medical history and medications with your doctor, and follow post-treatment care instructions. Common side effects include redness, swelling, pain, and itching.
For more information, visit Juvederm.com or consult your doctor. To report side effects, call the Allergan® Product Support Department at 1-877-345-5372.
SKINVIVE by JUVÉDERM® Injectable Gel Important Information
Approved for improving skin smoothness in adults over 21.
IMPORTANT SAFETY INFORMATION
Avoid SKINVIVE if you have severe allergies, or are allergic to lidocaine or Gram-positive bacterial proteins. Risks include unintentional injection into blood vessels. Discuss your medical history and any planned procedures with your specialist.
Common side effects include redness, lumps, and bruising. For more information, visit SKINVIVE.com or consult your specialist.
CoolSculpting® and CoolSculpting® Elite Important Safety Information
FDA-cleared for treating visible fat bulges and improving the appearance of lax tissue. Not a weight-loss treatment. Side effects include numbness and swelling. Rarely, visible enlargement may occur, requiring surgical intervention.
For more information, visit www.coolsculpting.com.
DiamondGlow® Uses and Important Safety Information
A dermabrasion device that removes the top layer of skin and delivers cosmetic serums. Not suitable for compromised skin quality. Common side effects include temporary tightness and redness. For more information, consult your provider.
SkinMedica® Important Information
Products are intended to beautify and alter appearances, not to diagnose, treat, cure, or prevent diseases. Not FDA-approved. Consult your provider for additional information.
